CORXEL Pharmaceuticals
Shanghai
About CORXEL Pharmaceuticals
CORXEL Pharmaceuticals is a global biotechnology company that develops and commercializes novel therapeutics to treat medical needs in cardiovascular and ophthalmic diseases. Their asset pipeline includes cardiology, ophthalmology, hypertrophic cardiomyopathy, heart failure, presbyopia, hypertension, and dry eye disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $451.8M
- Funding stage: Late Stage Venture
- Last round: Series D (Jan 2026)
- Website: corxelbio.com
- Phone: +86-021-80311808
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/corxel-pharmaceuticals-49677 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.